BioPharmSignal logoBioPharmSignal

Biotech News

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

IRIDEX (IRIX)IRIDEXFinancing

MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its

Related news

OTLKOutlook2026-08-13 01:45 EST

Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants

OTLKOutlook2026-08-12 20:01 EST

Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

EHCEncompass Health Corporation2026-08-10 20:30 EST

Encompass Health prices private offering of additional 5.875% senior notes due 2034

TARSTarsus Pharmaceuticals2026-08-06 11:02 EST

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

IRIXIRIDEX2026-08-18 20:05 EST

Iridex Reports Second Quarter 2026 Financial Results

EHCEncompass Health Corporation2026-08-10 12:28 EST

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

IRIXIRIDEX2026-08-04 20:05 EST

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

XAIRBeyond Air2026-07-30 11:00 EST

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

TMCITreace Medical Concepts2026-09-15 21:07 EST

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

ICCMIceCure Medical2026-08-06 12:05 EST

IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment

View all latest news

IRIDEX

Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...

Recent company news

IRIXIRIDEX2026-08-18 20:05 EST

Iridex Reports Second Quarter 2026 Financial Results

IRIXIRIDEX2026-08-04 20:05 EST

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

IRIXIRIDEX2026-07-20 11:00 EST

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

IRIXIRIDEX2026-06-09 20:05 EST

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

Stock data

Close
0.67 USD
Market cap
20.37M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States